Drugs Controller General of India

India yet to realise the full potential of digital health; crucial to develop models for their extension to rural India: DCGI – ET HealthWorld

by
India yet to realise the full potential of digital health; crucial to develop models for their extension to rural India: DCGI – ET HealthWorld

Mumbai: As digital technology is dominating the discourse of contemporary and future healthcare solutions, the Drugs Controller General of India (DGCI) has stressed that India is yet to fully realise that potential and it is crucial to develop models that ensure Digital Health solutions extend to rural India.” “Currently, most digital health solutions are concentrated … Read more

DCGI gives approval for Indian eye drops developed to reduce dependency on reading glasses

by
DCGI gives approval for Indian eye drops developed to reduce dependency on reading glasses

Image for representational purposes only. The Drugs Controller General of India (DCGI) has given its final approval for ENTOD Pharmaceuticals PresVu eye drops specifically developed to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40. The approval follows an earlier recommendation by the … Read more

Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

by
Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

DCGI Approved Corbevax Vaccine for 5 to 12 Years Age Group, Covaxin Vaccine for 6-12 Age Groups: The Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation (EUA) to Covaxin for use in 6 to 12 years old children. The national drug regulator has asked Covaxin manufacturer Bharat Biotech to submit safety data. … Read more

Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

by
Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group. Covovax is the fourth vaccine to receive EUA from … Read more

DGCI gives nod to SII’s proposal to manufacture Covid vaccine against Omicron variant for test, analysis

by
DGCI gives nod to SII’s proposal to manufacture Covid vaccine against Omicron variant for test, analysis

Director, Government and Regulatory Affairs at the SII, Prakash Kumar Singh had put in an application to the DCGI on January 6 stating the Pune-based firm, in collaboration with Novavax Inc, is working on the development of a vaccine against omicron, an official source said, adding that the SII has obtained permission and licence to … Read more

Government constitutes panel to frame new law for drugs, cosmetics, medical devices

by
Government constitutes panel to frame new law for drugs, cosmetics, medical devices

The government has constituted an eight-member panel for framing a new law for drugs, cosmetics and medical devices. The panel is being headed by Drugs Controller General of India (DCGI) Dr V G Somani. “The government has decided to constitute a committee for framing/preparation of the New Drugs, Cosmetics and Medical Devices Bill so that … Read more